Gastroenterology and Liver

Precision Medicine & Biomarkers in Gastroenterology & Hepatology

Precision medicine is reshaping the management of gastrointestinal and liver diseases by tailoring interventions based on genetic, molecular, and phenotypic profiles. This session will explore emerging biomarkers for disease diagnosis, prognosis, and therapeutic monitoring in conditions such as IBD, liver fibrosis, and GI cancers. Participants will learn about novel genomic, transcriptomic, proteomic, and metabolomic approaches that inform individualized treatment decisions. The track also covers strategies for integrating biomarker-driven therapies into clinical practice, enhancing patient outcomes and reducing adverse effects.

In addition, this session emphasizes translational research efforts that bridge laboratory discoveries to patient care. Case studies, clinical trial results, and real-world applications will illustrate the impact of precision medicine on treatment selection, disease monitoring, and long-term outcomes. Participants will gain insights into ongoing research opportunities, emerging technologies, and strategies for implementing biomarker-guided care. This track is ideal for clinicians, researchers, and scientists focused on advancing personalized approaches in gastroenterology and hepatology.